BIO-key Intl (NASDAQ:BKYI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.12) by 25 percent. This is a 61.54 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $1.550 million which missed the analyst consensus estimate of $1.800 million by 13.89 percent. This is a 27.74 percent decrease over sales of $2.145 million the same period last year.